86 related articles for article (PubMed ID: 1964564)
1. [Effects of ketanserin on glucose metabolism in hypertensive diabetic subjects].
Carleo R; Gobbo M; Bonavita M; De Matteo A; Gallo M; Gatti A
Boll Soc Ital Biol Sper; 1990 Jul; 66(7):639-46. PubMed ID: 1964564
[TBL] [Abstract][Full Text] [Related]
2. Ketanserin in chronic treatment of hypertension in type 2 diabetes mellitus.
Fogari R; Zoppi A; Pasotti C; Nicrosini S; Lazzari P; Corradi L
Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):218-22. PubMed ID: 2365539
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive and metabolic effects of ketanserin in diabetic patients with mild hypertension.
Beretta-Piccoli C; Salvadé G; Bachmann C; Riesen W; Zuppinger K
J Hum Hypertens; 1988 Aug; 2(2):103-10. PubMed ID: 3072419
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of the serotonin (5-HT)-2 receptor and insulin sensitivity: implications for atypical antipsychotics.
Gilles M; Wilke A; Kopf D; Nonell A; Lehnert H; Deuschle M
Psychosom Med; 2005; 67(5):748-51. PubMed ID: 16204433
[TBL] [Abstract][Full Text] [Related]
5. Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects.
Feher MD; Henderson AD; Wadsworth J; Poulter C; Gelding S; Richmond W; Sever PS; Elkeles RS
J Hum Hypertens; 1990 Oct; 4(5):571-7. PubMed ID: 1980930
[TBL] [Abstract][Full Text] [Related]
6. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
Al-Waili N
Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
[TBL] [Abstract][Full Text] [Related]
7. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat.
Persson B; Gradin K; Pettersson A; Hedner T
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S22-4. PubMed ID: 2459509
[TBL] [Abstract][Full Text] [Related]
9. The alpha-adrenergic receptor blocking effect of ketanserin and the interaction between alpha-adrenergic and S2-serotonergic receptor blockade.
van der Starre PJ; Reneman RS
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S54-61. PubMed ID: 2459516
[TBL] [Abstract][Full Text] [Related]
10. Haemodynamic and metabolic effects of ketanserin in dyslipidaemic hypertensive subjects.
Letizia C; Sellini M; Scavo D
Int J Tissue React; 1991; 13(2):91-3. PubMed ID: 1955297
[TBL] [Abstract][Full Text] [Related]
11. The acute and chronic antihypertensive effects of ketanserin cannot be explained by blockade of vascular serotonin, type 2, receptors or alpha 1-adrenergic receptors.
Blauw GJ; van Brummelen P; Doorenbos CJ; van der Velde EA; van Zwieten PA
Clin Pharmacol Ther; 1991 Apr; 49(4):377-84. PubMed ID: 1849810
[TBL] [Abstract][Full Text] [Related]
12. Quinapril reduces arterial blood pressure and improves metabolic control in elderly hypertensive diabetic patients.
Paolisso G; Gambardella A; Verza M; Varricchio M
Diabete Metab; 1990; 16(3):264-5. PubMed ID: 2210025
[No Abstract] [Full Text] [Related]
13. Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors.
Shen FM; Wang J; Ni CR; Yu JG; Wang WZ; Su DF
Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):702-7. PubMed ID: 17600544
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of slow release urapidil (ebrantil) in hypertensive patients with non-insulin dependent diabetes mellitus (NIDDM).
Oren S; Turkot S; Paran E; Flandra O; Slezak L; Hof B
J Hum Hypertens; 1996 Feb; 10(2):123-7. PubMed ID: 8867567
[TBL] [Abstract][Full Text] [Related]
15. Platelet deactivation by 5HT2-receptor blockade parallels the antihypertensive response to ketanserin.
Amstein R; Fetkovska N; Pletscher A; Bühler FR
J Hypertens; 1989 Apr; 7(4):255-60. PubMed ID: 2723427
[TBL] [Abstract][Full Text] [Related]
16. Influence of ketanserin on glucose and lipid metabolism in diabetic patients with hypertension.
Janka HU; Mehnert H; Fisher R; Seiler KU
Drugs; 1988; 36 Suppl 1():123-5. PubMed ID: 3240726
[No Abstract] [Full Text] [Related]
17. An investigation of the effects of intravenous injection of the 5-hydroxytryptamine 2 receptor antagonists ketanserin and LY 53857 on blood pressure in anesthetized spontaneously hypertensive rats.
Docherty JR
J Pharmacol Exp Ther; 1989 Feb; 248(2):736-40. PubMed ID: 2537414
[TBL] [Abstract][Full Text] [Related]
18. Does acute serotonergic type-2 antagonism reduce blood pressure? Comparative effects of single doses of ritanserin and ketanserin in essential hypertension.
Hosie J; Stott DJ; Robertson JI; Ball SG
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S86-8. PubMed ID: 2446081
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and hemodynamic effects of medium-term treatment with ketanserin of 2 comparative groups of obese and non-obese hypertensive patients].
Parrinello G
Ann Ital Med Int; 1990; 5(4 Pt 2):477-83. PubMed ID: 2102135
[TBL] [Abstract][Full Text] [Related]
20. Effect of nifedipine on glucose tolerance, serum insulin, and serum fructosamine in diabetic and nondiabetic patients.
Gill JS; Al-Hussary N; Zezulka AV; Pasi KJ; Atkins TW; Beevers DG
Clin Ther; 1987; 9(3):304-10. PubMed ID: 3300989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
